Skip to main content

A Review of Pharmaceutical Company Contributions

Carol Adelman

To view this report, please click on the “View PDF” button below.

View PDF

Related Articles

Stripping Intellectual Property Rights from COVID-19 Vaccines Is Disastrous

Adam Mossoff

The Covid-19 pandemic grinds on with the Delta variant dashing hopes of a return to normalcy this fall. Throughout, politicians and activists have mad...

Continue Reading

What You Need to Know About President Biden’s Prescription Drug Agenda

Adam Mossoff

On May 27, 2021, The Heritage Foundation held a virtual panel discussion on President Biden’s prescription drug agenda. Heritage’s Doug Badger and...

Continue Reading

Counterbalance | Ep. 19: Central Asia as a Strategic Concept

Michael Doran & Marshall Kosloff

Fred Starr, the former president of Oberlin College and Chairman of the Central Asia-Caucasus Institute, joins Mike and Marshall to discuss the role t...

Continue Reading